SuRo Capital price target raised to $10 from $8 at Citizens JMP

Citizens JMP analyst Devin Ryan raised the firm’s price target on SuRo Capital (SSSS) (SURO) to $10 from $8 and keeps an Outperform rating on the shares. The firm believes Q2 will mark an inflection point for SuRo Capital, following the significant appreciation in CoreWeave (CRWV), the analyst tells investors in a research note. Assuming SuRo sells its remaining stake in CoreWeave at current prices, this would result in a realized gain of about $30M, or roughly $1.25 per share, the firm says.